about
Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationThe connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNAThe interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assemblyThe selective packaging and annealing of primer tRNALys3 in HIV-1The tRNALys packaging complex in HIV-1Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export functionInability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.Cyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interactionRepetitive RNA unwinding by RNA helicase A facilitates RNA annealing.Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs.The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA.Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNAtRNA(Lys3): the primer tRNA for reverse transcription in HIV-1.Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.HIV-1 modulates the tRNA pool to improve translation efficiency.Roles of the linker region of RNA helicase A in HIV-1 RNA metabolismCellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly.Export of Precursor tRNAIle from the Nucleus to the Cytoplasm in Human Cells.The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA.Inhibition of HIV-1 assembly by coiled-coil domain containing protein 8 in human cells.Dual role for motif 1 residues of human lysyl-tRNA synthetase in dimerization and packaging into HIV-1Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-polFormation of the tRNALys packaging complex in HIV-1.Aspects of HIV-1 assembly that promote primer tRNA(Lys3) annealing to viral RNA.Role of the OB-fold of RNA helicase A in the synthesis of HIV-1 RNA.Helicase associated 2 domain is essential for helicase activity of RNA helicase A.In vitro and in vivo analysis of the interaction between RNA helicase A and HIV-1 RNA.Role of RNA in facilitating Gag/Gag-Pol interaction.Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.A structurally disordered region at the C terminus of capsid plays essential roles in multimerization and membrane binding of the gag protein of human immunodeficiency virus type 1.
P50
Q24669993-1D42B12A-EA6C-4579-B20D-99D60912B7A4Q24806162-2A4AEC8A-2515-441D-A0C9-357518591611Q28205104-B355AFFA-CA5D-43CA-99D4-954D4DA3ACF0Q28255952-F5F5658F-0781-4BE9-A9FC-64688462706BQ28265494-F812CD68-E741-4DF4-AEEB-83ADFE4B89CBQ28289911-0EA97436-8C50-4A3C-A8B4-54E41846BFCEQ30439541-FBBD100B-5FAC-4E60-AB11-F14ABF0AE108Q31046491-2056CF22-F15D-436A-840E-1FD044930A64Q33983533-E2462DC1-4E51-4495-97C1-1DE00E7EC44CQ34344599-140CDCAC-D200-4CF7-8307-48987E9E61C6Q34353288-CF030F2E-AC53-47AB-B3E4-52A01D9804B8Q34468488-3E99AB1C-84F6-4D28-90BB-4C8A39AB76EAQ34529769-42B64F6D-F2D8-4B6C-A714-FE4BFFE93C1FQ34670723-109274F3-3074-4869-9DE9-21CF75C1BFB3Q34781698-F5DB38F2-53C7-4C86-870A-9DCEF1583144Q34994062-BB34D65E-C2BD-4F69-B060-4632EFED83D7Q35040210-34E01BB3-438A-4529-86F4-36D8096C8F8FQ35123403-55C35B8B-F818-482A-9AB9-DF64AC617715Q35996239-88925811-D0F1-420E-8FBD-7BD87A1CA65BQ36099305-4C792EDC-48F1-4053-A2DA-579A49B76057Q36109674-26B63E8B-76A9-46B4-8C13-8478EEC63079Q36451947-02DF89DB-6B7B-47D9-B0C0-9A29607574DFQ36942505-BA10CFEC-7B9C-4044-BECC-35B152C55E57Q37633035-CA5638ED-396F-429D-BE24-8A28369B4CDEQ38018767-C6A84B9A-67F5-48AD-A87A-EDFB6FE006A0Q38304779-4D8E5A1C-4260-43ED-B3B2-7AE5AC055E2EQ38305494-3F45A4F7-EC14-4C06-860C-10673AE26590Q38321340-5EB8AAB2-F45E-4F37-9A0D-4489EAC6C53CQ39683238-32431A30-3339-4E3B-A35B-711D3515BF47Q39685850-23F193CA-9367-4792-A118-422063DEDF72Q39698271-D7ADCA4F-D9A0-467A-B59A-278C03741B6FQ39699793-A46AE882-D714-4B08-9511-96F10CA98C3D
P50
description
onderzoeker
@nl
name
Lawrence Kleiman
@ast
Lawrence Kleiman
@en
Lawrence Kleiman
@es
Lawrence Kleiman
@nl
Lawrence Kleiman
@sl
type
label
Lawrence Kleiman
@ast
Lawrence Kleiman
@en
Lawrence Kleiman
@es
Lawrence Kleiman
@nl
Lawrence Kleiman
@sl
prefLabel
Lawrence Kleiman
@ast
Lawrence Kleiman
@en
Lawrence Kleiman
@es
Lawrence Kleiman
@nl
Lawrence Kleiman
@sl